Thu, Feb 26, 2015, 7:06 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Medivation, Inc. (MDVN) Message Board

  • berkelygenie berkelygenie Mar 7, 2013 1:57 PM Flag

    DNDN at $6.08 worth more than MDVN

    DNDN charges the same price for its drug with the same result, but DNDN owns 100% of its drug, not 50% like MDVN. DNDN doesn't have to give 10% of its profits to UCLA. DNDN has more applications of its drug and its revenues are nearly double MDVN. MDVN lost its patent battle with generation 2 Xtandi, called ARN509.
    ARN509 will be approved within a year and its doesn't cause seizures like Xtandi, and it is easier and cheaper to produce.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
119.74+5.900(+5.18%)Feb 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.